Welcome to the PMBug forums - a community supported watering hole for folks interested in gold, silver, precious metals, sound money, investing, market and economic news, central bank monetary policies, politics and more.
Register a free account to join the discussions. When you register an account and log in, you may enjoy additional benefits including access to market data/charts and additional members only rooms (including one for trade/barter with the community).
How often and how much?My wife and I take ivermectin monthly since she got parasites.
It comes intablet form. Bery inexpensive from india. Go to cheapmedicineshop.com.How often and how much?
Abstract
Background/aim: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole demonstrate multi-target anticancer activity in preclinical models. This study evaluates real-world patient-reported outcomes, safety, and adherence in patients with cancer using this combination.
Patients and methods: We analyzed a prospective observational cohort of 197 patients with cancer prescribed ivermectin and mebendazole off-label via a U.S. telemedicine platform. Participants received compounded capsules (25 mg ivermectin, 250 mg mebendazole). Data were collected through standardized digital surveys at baseline and 6-month follow-up. A total of 122 participants (61.9%) completed follow-up. Primary outcomes included self-reported cancer status, adherence, and adverse events. Confidence intervals were calculated using the Wilson method, with dose-stratified analyses using Chi-square tests.
Results: The cohort had a mean age of 67 years with balanced sex distribution and diverse malignancies, most commonly prostate (27.9%) and breast (18.3%). Median time since diagnosis was 1.2 years, with 37.1% reporting active progression at baseline. At six months, adherence was high, with 86.9% completing the initial prescription and 66.4% remaining on therapy. The Clinical Benefit Ratio (CBR) was 84.4% (95% confidence interval=77.0-89.8%). At follow-up, 48.4% of participants reported tumor regression or no evidence of disease (32.8% NED; 15.6% regression), while 36.1% reported stable disease and 15.6% reported progression. Side effects, reported by 25.4%, were dose-dependent and predominantly mild and primarily gastrointestinal, with 93.6% continuing therapy after adjustment. Concurrent therapies reported included chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%).
Conclusion: In this prospective real-world cohort of patients with cancer, ivermectin and mebendazole were associated with high rates of self-reported clinical benefit and favorable tolerability. These findings are hypothesis-generating and support the need for randomized controlled trials.
My wife and I take ivermectin monthly since she got parasites.
I was asking about frequency and dosages.It comes intablet form. Bery inexpensive from india. Go to cheapmedicineshop.com.
IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION
1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day).
LOW DOSE: ≤ 0.5 mg/kg/day
**Best for:**
- Cancers in remission
- Strong family history or genetic predisposition
- Prophylaxis (preventive)
**Side effects:** No long-term side effects reported.
**Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished.
MEDIUM DOSE: 1.0 mg/kg/day
**Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9.
HIGH DOSE: 2.0 mg/kg/day
**Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared.
VERY HIGH DOSE: ≥ 2.5 mg/kg/day
**Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers.
**Side effects:** Possible short-term & transient visual effects (usually resolve in a few days).
**Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported.
**Quick conversion example (for a 60 kg / 132 lb person):**
- Low: ≤30 mg/day
- Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid)
- High: 120 mg/day
- Very High: ≥150 mg/day
Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary.
Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only.
...
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?